Nephros (NEPH) FCF Margin Growth (3y) (2013 - 2026)
Nephros (NEPH) FCF Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.42 Bn | 129.20 Bn | 1.96 Bn | 503.00 |
| 2 | Becton Dickinson | 52.62 Bn | 51.76 Bn | 2.32 Bn | -554.00 |
| 3 | Alcon | 35.73 Bn | 34.37 Bn | 1.68 Bn | -1,343.00 |
| 4 | Resmed | 33.68 Bn | 32.21 Bn | 861.22 Mn | 948.00 |
| 5 | Medline | 29.26 Bn | 26.59 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 24.99 Bn | 24.55 Bn | 329.20 Mn | -318.00 |
| 7 | Solventum | 15.42 Bn | 15.02 Bn | 1.29 Bn | -769.00 |
| 8 | Cooper Companies | 14.83 Bn | 14.69 Bn | 735.40 Mn | 315.00 |
| 9 | Baxter International | 13.52 Bn | 11.37 Bn | 1.03 Bn | -114.00 |
| 10 | Nephros | 43.75 Mn | 39.05 Mn | 4.03 Mn | 494.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 494.00 |
| Mar 31, 2026 | -3,953.00 |
| Dec 31, 2025 | 1,154.00 |
| Sep 30, 2025 | 913.00 |
| Jun 30, 2025 | 6,372.00 |
| Mar 31, 2025 | 9,141.00 |
| Dec 31, 2024 | 4,604.00 |
| Sep 30, 2024 | 1,809.00 |
| Jun 30, 2024 | -1,024.00 |
| Mar 31, 2024 | -1,623.00 |
| Dec 31, 2023 | 5,699.00 |
| Sep 30, 2023 | 10,226.00 |
| Jun 30, 2023 | 11,544.00 |
| Mar 31, 2023 | 8,022.00 |
| Dec 31, 2022 | -1,914.00 |
| Sep 30, 2022 | 1,278.00 |
| Jun 30, 2022 | 1,633.00 |
| Mar 31, 2022 | -4,541.00 |
| Dec 31, 2021 | 2,041.00 |
| Sep 30, 2021 | 2,928.00 |